Some of functionality may not work while you disabled JavaScript. Enable JavaScript for better User Exprience.
Access here alternative investment news about Imbed Biosciences Closes $2M In Series A Financing To Commercialize Its Wound Healing Matrix
Venture Capital

Imbed Biosciences Closes $2M In Series A Financing To Commercialize Its Wound Healing Matrix

by businesswire.com posted 4months ago 16 views
MADISON, Wis.--(BUSINESS WIRE)--lt;a href="https://twitter.com/hashtag/Financing?src=hash" target="_blank"gt;#Financinglt;/agt;--Imbed Biosciences closes $2M in Series A financing to commercialize next-generation FDA-cleared wound healing matrix. : MADISON, Wis.--(BUSINESS WIRE)--Imbed Biosciences Inc. (Imbed), a medical device company emerging as a leader in the development of advanced therapies for soft tissue repair, announced today that it has closed $2 million in a Series A Preferred Stock equity financing.